IL128205A - Indane derivatives and pharmaceutical compositions containing the same - Google Patents
Indane derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL128205A IL128205A IL12820597A IL12820597A IL128205A IL 128205 A IL128205 A IL 128205A IL 12820597 A IL12820597 A IL 12820597A IL 12820597 A IL12820597 A IL 12820597A IL 128205 A IL128205 A IL 128205A
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- indane derivatives
- indane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Magnetic Heads (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Optical Communication System (AREA)
- Separation By Low-Temperature Treatments (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2254796P | 1996-07-26 | 1996-07-26 | |
US08/893,160 US6083986A (en) | 1996-07-26 | 1997-07-15 | Potassium channel inhibitors |
PCT/US1997/012559 WO1998004521A1 (fr) | 1996-07-26 | 1997-07-23 | Inhibiteurs du canal de potassium |
Publications (2)
Publication Number | Publication Date |
---|---|
IL128205A0 IL128205A0 (en) | 1999-11-30 |
IL128205A true IL128205A (en) | 2003-09-17 |
Family
ID=26696048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12820597A IL128205A (en) | 1996-07-26 | 1997-07-23 | Indane derivatives and pharmaceutical compositions containing the same |
Country Status (13)
Country | Link |
---|---|
US (1) | US6083986A (fr) |
EP (1) | EP0923543B1 (fr) |
JP (1) | JP2002513385A (fr) |
KR (1) | KR20000029605A (fr) |
AT (1) | ATE250571T1 (fr) |
AU (1) | AU734711B2 (fr) |
BR (1) | BR9710587A (fr) |
CA (1) | CA2261814A1 (fr) |
DE (1) | DE69725153T2 (fr) |
HK (1) | HK1020334A1 (fr) |
HU (1) | HUP0003250A3 (fr) |
IL (1) | IL128205A (fr) |
WO (1) | WO1998004521A1 (fr) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1003495A4 (fr) * | 1997-07-22 | 2002-08-28 | Lilly Co Eli | Composes pharmaceutiques |
US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
CO5090829A1 (es) * | 1998-07-21 | 2001-10-30 | Novartis Ag | Compuestos organicos de la formula i, utiles como inhibido res de la proteina de transferencia de triglicerido microso mal y de la secrecion de la apolipoproteina b. |
US6197798B1 (en) | 1998-07-21 | 2001-03-06 | Novartis Ag | Amino-benzocycloalkane derivatives |
EP1109544A4 (fr) * | 1998-09-01 | 2004-10-27 | Bristol Myers Squibb Co | Inhibiteurs de canaux potassium et leur methode d'utilisation |
US6303637B1 (en) | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
US6632836B1 (en) | 1998-10-30 | 2003-10-14 | Merck & Co., Inc. | Carbocyclic potassium channel inhibitors |
US6194458B1 (en) | 1998-10-30 | 2001-02-27 | Merck & Co., Inc. | Benzamide potassium channel inhibitors |
DE19929076A1 (de) * | 1999-06-25 | 2000-12-28 | Aventis Pharma Gmbh | Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
EP1214293A1 (fr) * | 1999-09-08 | 2002-06-19 | Guilford Pharmaceuticals Inc. | Composes non-peptidiques de liaison cyclophiline et leur utilisation |
US6531495B1 (en) | 1999-10-02 | 2003-03-11 | Aventis Pharma Deutschland Gmbh | 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
WO2001046155A1 (fr) * | 1999-12-21 | 2001-06-28 | Icagen, Inc. | Inhibiteurs des canaux potassiques |
ES2240420T3 (es) | 2000-01-18 | 2005-10-16 | Novartis Ag | Carboxamidas utiles como inhibidores de la proteina de transferencia de trigliceridos microsomicos y de la secrecion de apolipoproteina b. |
US6566380B2 (en) * | 2000-07-25 | 2003-05-20 | Icagen, Inc. | Potassium channel inhibitors |
US6620849B2 (en) | 2000-07-26 | 2003-09-16 | Icafen, Inc. | Potassium channel inhibitors |
AU2002214522A1 (en) * | 2000-11-17 | 2002-05-27 | Karolinska Innovations Ab | Nucleotide and polypeptide sequences of kcna7, a mammalian voltage-gated potassium channel protein, and use thereof |
DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
DE10060807A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
DE10061876A1 (de) | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
US6849634B2 (en) | 2000-12-21 | 2005-02-01 | Icagen | Potassium channel inhibitors |
US6656971B2 (en) | 2001-01-25 | 2003-12-02 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
DE10121003A1 (de) | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
US10078087B2 (en) | 2001-05-01 | 2018-09-18 | Senomyx, Inc. | Assays and enhancers of the human delta ENaC sodium channel |
US20040072254A1 (en) * | 2001-05-01 | 2004-04-15 | Senomyx, Inc. | High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds |
AU2002314132A1 (en) * | 2001-05-31 | 2002-12-09 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | New heterotetrameric potassium channels and uses thereof |
DE10128331A1 (de) | 2001-06-12 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
TW200403058A (en) | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
GB0315950D0 (en) | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
CA2530497A1 (fr) | 2003-07-10 | 2005-02-17 | Senomyx, Inc. | Dosages electrophysiologiques ameliores mettant en oeuvre des ovocytes d'expression du canal sodique epithelial humain et l'utilisation de phenamil pour ameliorer l'effet d'amplificateurs de canal sodique epithelial dans des dosages au moyen de colorants rapporteurs a potentiel membranaire |
KR100820511B1 (ko) * | 2004-04-01 | 2008-04-11 | 파마시아 앤드 업존 캄파니 엘엘씨 | 결정성 피라졸 유도체 |
GB0412986D0 (en) | 2004-06-10 | 2004-07-14 | Xention Discovery Ltd | Compounds |
WO2006115509A2 (fr) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence |
US7576212B2 (en) | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
US8565898B2 (en) * | 2005-04-28 | 2013-10-22 | Medtronic, Inc. | Rate control during AF using cellular intervention to modulate AV node |
GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
US8633160B2 (en) * | 2005-12-30 | 2014-01-21 | Nono Inc. | Small molecule inhibitors of PDZ interactions |
KR20090083479A (ko) * | 2006-11-28 | 2009-08-03 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체 |
WO2009006611A1 (fr) * | 2007-07-03 | 2009-01-08 | Arbor Vita Corporation | Inhibiteurs de petites molécules d'interactions pdz |
US8653100B2 (en) | 2008-04-01 | 2014-02-18 | Abbvie Inc. | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815784D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
JP2012523393A (ja) * | 2009-04-09 | 2012-10-04 | エム・エス・ディー・オス・ベー・フェー | インダン誘導体 |
GB0909672D0 (en) | 2009-06-04 | 2009-07-22 | Xention Discovery Ltd | Compounds |
GB0909671D0 (en) | 2009-06-04 | 2009-07-22 | Xention Discovery Ltd | Compounds |
US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
GB201105659D0 (en) | 2011-04-01 | 2011-05-18 | Xention Ltd | Compounds |
US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
BR112013029201B1 (pt) | 2011-05-13 | 2022-08-09 | Array Biopharma Inc | Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas |
NO3175985T3 (fr) | 2011-07-01 | 2018-04-28 | ||
WO2013020930A1 (fr) | 2011-08-05 | 2013-02-14 | Abbott Gmbh & Co. Kg | Dérivés d'aminochromane, d'aminothiochromane et d'amino-1,2,3,4-tétrahydroquinoléine, compositions pharmaceutiques contenant ceux-ci et leur utilisation thérapeutique |
JP2014533675A (ja) | 2011-11-18 | 2014-12-15 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | N置換アミノベンゾシクロヘプテン、アミノテトラリン、アミノインダンおよびフェナルキルアミン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
US20150045305A1 (en) | 2012-01-27 | 2015-02-12 | Gilead Sciences, Inc. | Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
WO2013130808A1 (fr) | 2012-02-29 | 2013-09-06 | D.E. Shaw Research, Llc | Procédés pour le criblage de protéines sensibles à la tension |
WO2014078417A1 (fr) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | Composés de pyrazolylurée, d'urée, de thiourée, de guanidine et de cyanoguianidine en tant qu'inhibiteurs de la trka kinase |
UA116455C2 (uk) | 2012-11-13 | 2018-03-26 | Еррей Біофарма Інк. | Сполуки n-піролідинілсечовини, n'-піразолілсечовини, тіосечовини, гуанідину та ціаногуанідину як інгібітори кінази trka |
WO2014078322A1 (fr) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | Composés de thiazolyl-urée, oxazolyl-urée, thio-urée, guanidine et cyanoguanidine en tant qu'inhibiteurs de la kinase trka |
RU2664541C2 (ru) | 2012-11-13 | 2018-08-20 | Эррэй Биофарма Инк. | Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли |
WO2014078325A1 (fr) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | Composés de n-aryle monocycliques, n'-pyrazolyl-urée, thiourée, guanidine et cyanoguanidine utiles comme inhibiteurs de trka kinase |
US9969694B2 (en) | 2012-11-13 | 2018-05-15 | Array Biopharma Inc. | N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
US9828360B2 (en) | 2012-11-13 | 2017-11-28 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
US9822118B2 (en) | 2012-11-13 | 2017-11-21 | Array Biopharma Inc. | Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
US9790178B2 (en) | 2012-11-13 | 2017-10-17 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
US9546156B2 (en) | 2012-11-13 | 2017-01-17 | Array Biopharma Inc. | N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors |
US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
AU2014336153A1 (en) | 2013-10-17 | 2016-04-28 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
JP2016533375A (ja) | 2013-10-17 | 2016-10-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
RS59286B1 (sr) | 2014-05-15 | 2019-10-31 | Array Biopharma Inc | 1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea kao inhibitor trka kinaze |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB536939A (en) * | 1939-08-24 | 1941-06-03 | Eastman Kodak Co | Improvements in and relating to photographic colour development |
IL62973A0 (en) * | 1980-06-02 | 1981-07-31 | Basf Ag | Aralkylphenylureas,their manufacture and their use as herbicides |
JPS60199862A (ja) * | 1984-03-23 | 1985-10-09 | Otsuka Pharmaceut Co Ltd | インダン誘導体 |
GB8707123D0 (en) * | 1987-03-25 | 1987-04-29 | Pfizer Ltd | Antiarrhythmic agents |
US5006512A (en) * | 1987-10-02 | 1991-04-09 | Tsuyoshi Ohnishi | Therapeutic usages of inhibitors for a potassium efflux channel |
IL88314A (en) * | 1987-11-18 | 1994-05-30 | Tanabe Seiyaku Co | History of sulfonylamino indane, their preparation and pharmaceutical preparations containing them |
DK691488A (da) * | 1987-12-14 | 1989-06-15 | Beecham Group Plc | Hidtil ukendte forbindelser |
US5242947A (en) * | 1988-02-10 | 1993-09-07 | New York University | Use of polyamines as ionic-channel regulating agents |
DE3818245A1 (de) * | 1988-05-28 | 1989-12-07 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln |
US5215985A (en) * | 1990-07-20 | 1993-06-01 | E. R. Squibb & Sons, Inc. | Method for treating ischemic insult to neurons employing an ATP-sensitive potassium channel blocker |
ATE167473T1 (de) * | 1990-08-20 | 1998-07-15 | Eisai Co Ltd | Sulfonamid-derivate |
US5401848A (en) * | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
US5310932A (en) * | 1991-04-15 | 1994-05-10 | E. R. Squibb & Sons, Inc. | Chromanyl substituted indole potassium channel openers |
US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
US5356775A (en) * | 1992-07-29 | 1994-10-18 | Brigham & Women's Hospital | Primary structure for functional expression from complementary DNA of a mammalian ATP-sensitive potassium channel |
US5328830A (en) * | 1992-09-08 | 1994-07-12 | Miles Inc. | Potassium channel modulators |
US5374643A (en) * | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
US5453421A (en) * | 1992-09-11 | 1995-09-26 | E. R. Squibb & Sons, Inc. | Aryl and heterocyclic substituted propenamide derivatives |
DE4302051A1 (de) * | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
GB9309716D0 (en) * | 1993-05-12 | 1993-06-23 | Zeneca Ltd | Heterocyclic derivatives |
US5401758A (en) * | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
DE69535315T2 (de) * | 1994-01-10 | 2007-06-28 | Teva Pharmaceutical Industries Ltd. | 1-aminoindanderivate und zusammensetzungen hiervon |
FR2717805B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant . |
US5615460A (en) * | 1994-06-06 | 1997-04-01 | The Procter & Gamble Company | Female component for refastenable fastening device having regions of differential extensibility |
ZA96211B (en) * | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
AU5772396A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
CA2243717A1 (fr) * | 1996-01-22 | 1997-07-24 | Philip Floyd Hughes | Derives d'indane destines a des compositions antipsychotiques |
-
1997
- 1997-07-15 US US08/893,160 patent/US6083986A/en not_active Expired - Lifetime
- 1997-07-23 AT AT97934996T patent/ATE250571T1/de not_active IP Right Cessation
- 1997-07-23 AU AU38035/97A patent/AU734711B2/en not_active Ceased
- 1997-07-23 EP EP97934996A patent/EP0923543B1/fr not_active Expired - Lifetime
- 1997-07-23 KR KR1019997000669A patent/KR20000029605A/ko active IP Right Grant
- 1997-07-23 IL IL12820597A patent/IL128205A/xx not_active IP Right Cessation
- 1997-07-23 WO PCT/US1997/012559 patent/WO1998004521A1/fr active IP Right Grant
- 1997-07-23 HU HU0003250A patent/HUP0003250A3/hu unknown
- 1997-07-23 BR BR9710587-2A patent/BR9710587A/pt not_active Application Discontinuation
- 1997-07-23 DE DE69725153T patent/DE69725153T2/de not_active Expired - Fee Related
- 1997-07-23 CA CA002261814A patent/CA2261814A1/fr not_active Abandoned
- 1997-07-23 JP JP50888498A patent/JP2002513385A/ja not_active Ceased
-
1999
- 1999-11-26 HK HK99105493A patent/HK1020334A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR9710587A (pt) | 2000-10-31 |
US6083986A (en) | 2000-07-04 |
DE69725153D1 (de) | 2003-10-30 |
JP2002513385A (ja) | 2002-05-08 |
EP0923543A1 (fr) | 1999-06-23 |
HUP0003250A3 (en) | 2002-02-28 |
CA2261814A1 (fr) | 1998-02-05 |
AU734711B2 (en) | 2001-06-21 |
KR20000029605A (ko) | 2000-05-25 |
EP0923543B1 (fr) | 2003-09-24 |
ATE250571T1 (de) | 2003-10-15 |
AU3803597A (en) | 1998-02-20 |
WO1998004521A1 (fr) | 1998-02-05 |
HK1020334A1 (en) | 2000-04-14 |
IL128205A0 (en) | 1999-11-30 |
DE69725153T2 (de) | 2004-06-09 |
HUP0003250A1 (hu) | 2002-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL128205A (en) | Indane derivatives and pharmaceutical compositions containing the same | |
PL341859A1 (en) | Potassium channel inhibitors | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
AU5624699A (en) | Use of 5ht-6 antagonists | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
AP2002002458A0 (en) | Compounds for the treatment of ischemia. | |
BG102872A (en) | 6-phenylpyridyl-3-amine derivatives | |
HUP9901207A3 (en) | Kinazoline derivatives as irreversible inhibitors of protein-kinase, their intermediates, pharmaceutical compositions containing these compounds and use thereof | |
AU2332188A (en) | Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors | |
AU2275397A (en) | Troponin subunits and fragments useful as angiogenesis inhibitors | |
AU2443184A (en) | Benzazocinones and benzazoninones | |
YU40203A (sh) | Orto-supstituisana bis-aril jedinjenja, koja sadrže azot, primenjena kao inhibitori kalijumovog kanala | |
AU2740797A (en) | Androstene derivatives | |
IE863279L (en) | Plasminogen activator composition | |
MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
PL356100A1 (en) | Lipoxin a4 | |
IL134930A0 (en) | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same | |
AU3251597A (en) | Composition and methods for modulating the length of telomeres | |
MY133682A (en) | Substituted pyrroles | |
MY102026A (en) | Antiasthmatic. | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents | |
IT1269740B (it) | Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB20 | Patent renewed for 20 years | ||
EXP | Patent expired |